A detailed history of Aimz Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 21,816 shares of VRTX stock, worth $10.2 Million. This represents 3.44% of its overall portfolio holdings.

Number of Shares
21,816
Previous 22,291 2.13%
Holding current value
$10.2 Million
Previous $9.07 Million 0.55%
% of portfolio
3.44%
Previous 3.71%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $193,652 - $211,888
-475 Reduced 2.13%
21,816 $9.12 Million
Q4 2023

Jan 26, 2024

SELL
$343.0 - $410.68 $90,895 - $108,830
-265 Reduced 1.17%
22,291 $9.07 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $18,261 - $19,572
-54 Reduced 0.24%
22,556 $7.84 Million
Q2 2023

Aug 08, 2023

SELL
$314.42 - $351.91 $18,865 - $21,114
-60 Reduced 0.26%
22,610 $7.96 Million
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $52,397 - $59,773
-185 Reduced 0.81%
22,670 $7.14 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $64,296 - $72,333
-225 Reduced 0.97%
22,855 $6.6 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $17,798 - $19,859
-65 Reduced 0.28%
23,080 $6.68 Million
Q2 2022

Aug 02, 2022

SELL
$234.96 - $292.55 $5,874 - $7,313
-25 Reduced 0.11%
23,145 $6.52 Million
Q1 2022

May 06, 2022

SELL
$221.42 - $260.97 $201,492 - $237,482
-910 Reduced 3.78%
23,170 $6.05 Million
Q4 2021

Feb 09, 2022

BUY
$177.01 - $223.45 $70,804 - $89,380
400 Added 1.69%
24,080 $5.29 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $2.9 Million - $3.25 Million
16,005 Added 208.53%
23,680 $4.3 Million
Q2 2021

Aug 05, 2021

BUY
$187.49 - $221.1 $28,123 - $33,165
150 Added 1.99%
7,675 $1.55 Million
Q1 2021

Apr 28, 2021

BUY
$207.02 - $241.31 $1.56 Million - $1.82 Million
7,525 New
7,525 $1.62 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.